Deakin University
dwyer-blockadeofa2a-2013.pdf (845.69 kB)

Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors

Download (845.69 kB)
journal contribution
posted on 2013-09-03, 00:00 authored by Paul A Beavis, Upulie Divisekera, Christophe Paget, Melvyn T Chow, Liza B John, Christel Devaud, Karen DwyerKaren Dwyer, John Stagg, Mark J Smyth, Phillip K Darcy
CD73 inhibits antitumor immunity through the activation of adenosine receptors expressed on multiple immune subsets. CD73 also enhances tumor metastasis, although the nature of the immune subsets and adenosine receptor subtypes involved in this process are largely unknown. In this study, we revealed that A2A/A2B receptor antagonists were effective in reducing the metastasis of tumors expressing CD73 endogenously (4T1.2 breast tumors) and when CD73 was ectopically expressed (B16F10 melanoma). A2A(-/-) mice were strongly protected against tumor metastasis, indicating that host A2A receptors enhanced tumor metastasis. A2A blockade enhanced natural killer (NK) cell maturation and cytotoxic function in vitro, reduced metastasis in a perforin-dependent manner, and enhanced NK cell expression of granzyme B in vivo, strongly suggesting that the antimetastatic effect of A2A blockade was due to enhanced NK cell function. Interestingly, A2B blockade had no effect on NK cell cytotoxicity, indicating that an NK cell-independent mechanism also contributed to the increased metastasis of CD73(+) tumors. Our results thus revealed that CD73 promotes tumor metastasis through multiple mechanisms, including suppression of NK cell function. Furthermore, our data strongly suggest that A2A or A2B antagonists may be useful for the treatment of metastatic disease. Overall, our study has potential therapeutic implications given that A2A/A2B receptor antagonists have already entered clinical trials in other therapeutic settings.



Proceedings of the National Academy of Sciences of the United States of America






14711 - 14716


National Academy of Sciences


Washington, D.C.





Publication classification

C1 Refereed article in a scholarly journal

Copyright notice

2013, National Academy of Sciences